Holen Sie sich die Stockscreener-App
6.38
11.14%
-0.80
Handel nachbörslich:
6.38
Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten
Emergent BioSolutions stock falls as CFO plans retirement - Investing.com
Emergent BioSolutions CFO to retire, treasurer named interim - Investing.com
Emergent BioSolutions Inc. Announces Chief Financial Officer Changes - marketscreener.com
Emergent BioSolutions (EBS) CFO Richard Lindahl to Retire, Shares Drop Premarket - GuruFocus
Emergent Biosolutions Announces Retirement of Richard S. Lindahl as Executive Vice President, Effective December 31, 2026 - www.marketscreener.com
Emergent BioSolutions CFO Richard Lindahl to Retire, Frank Vargo Named Interim Successor - citybiz
Emergent BioSolutions (EBS) CFO Richard Lindahl to Retire; Inter - GuruFocus
Emergent BioSolutions CFO Richard Lindahl to retire end of 2026 - StreetInsider
Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl - Business Wire
Press Release: Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026 - Moomoo
Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026 - Business Wire
Emergent BioSolutions Director Donald W. DeGolyer Sells 17,800 Shares on October 7, 2026 - Kalkine Media
Form 4 Emergent Biosolutions Inc For: 7 October By Investing.com - Investing.com Canada
Emergent BioSolutions director DeGolyer sells $126k in shares - Investing.com
Director Donald DeGolyer proposes selling 17,800 Emergent BioSolutions (NYSE: EBS) shares. - Stock Titan
To cover stock-award taxes, an Emergent BioSolutions (EBS) director sold 17,800 shares under a trading plan. - Stock Titan
EBS5025998 Bond Profile: Coupon and Redemption - TradingView
Emergent Biosolutions (EBS) Soars 14.4%: Is Further Upside Left in the Stock? - Zacks Investment Research
Emergent Biosolutions (EBS) Soars 14.4%: Is Further Upside Left in the Stock? - Yahoo Finance
Form 4 Emergent Biosolutions Inc For: 5 October By Investing.com - Investing.com South Africa
Emergent BioSolutions (EBS) SVP, Products Business Paul Williams Sells 3,000 Shares - GuruFocus
Why is Emergent Biosolutions stock surging today? - Investing.com
Emergent BioSolutions stock gains 7.11 percent on October 5 - AD HOC NEWS
Emergent BioSolutions SVP Paul Williams sells $19,590 in stock - Investing.com
Form 4 Emergent Biosolutions Inc For: 5 October By Investing.com - Investing.com UK
Under a trading plan, Emergent BioSolutions (EBS) officer Williams sold 3,000 shares at $6.53. - Stock Titan
Emergent BioSolutions Inc. Common Stock (NYSE:EBS) Detailed Stock Data - The Chronicle-Journal
A 3,000-share sale is proposed by Emergent BioSolutions (EBS) officer Paul Williams. - Stock Titan
Emergent BioSolutions Inc. (EBS) Investigation: Bronstein, Gewirt - The National Law Review
Precision Trading with Emergent Biosolutions Inc. (EBS) Risk Zones - news.stocktradersdaily.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc.EBS - PR Newswire
Emergent BioSolutions Inc (ER4.DU) Analyst insights, Price targets and RecommendationsYahoo Finance - Yahoo Finance Singapore
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc.EBS - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc.EBS - FinancialContent
Emergent BioSolutions stock steady as investors weigh recent fundamentals - AD HOC NEWS
Emergent BioSolutions Inc. (EBS) Stock Analysis: Unpacking A 56.7% Potential Upside - DirectorsTalk Interviews
Emergent BioSolutions restarts Massachusetts manufacturing after $34.5M vaccine deal - The Business Journals
Emergent BioSolutions presents transformation update, Q2 results, $40M restructuring savings and revised FY26 guidance - TradingView
Intravenous Immunoglobulin Market Size Worth USD 30.83 Billion by 2035, Growing at 7.49% CAGR – SNS Insider - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc.EBS - GlobeNewswire Inc.
Emergent Biosolutions Inc (EBS) Fundamental & Financial Data - Stocktwits
Emergent BioSolutions: Tough 2026 Outlook Warrant Rating Downgrade (NYSE:EBS) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Encourages Emergent BioSolutions Inc. (EBS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Emergent Biosolutions Stock Price Forecast. Should You Buy EBS? - StockInvest.us
Bronstein, Gewirtz & Grossman, LLC Encourages Emergent BioSolutio - The National Law Review
Emergent BioSolutions repurchases $75 million in senior notes By Investing.com - Investing.com South Africa
Bronstein, Gewirtz & Grossman, LLC Is Investigating Emergent BioSolutions Inc. (EBS) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Emergent BioS - The National Law Review
Emergent BioSolutions repurchases $75 million in senior notes By Investing.com - Investing.com Australia
Emergent BioSolutions Repurchases $75 Million of Debt at Discount - citybiz
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):